Country: United States
Language: English
Source: NLM (National Library of Medicine)
ESMOLOL HYDROCHLORIDE (UNII: V05260LC8D) (ESMOLOL - UNII:MDY902UXSR)
West Ward Pharmaceutical Corporation
ESMOLOL HYDROCHLORIDE
ESMOLOL HYDROCHLORIDE 10 mg in 1 mL
INTRAVENOUS
PRESCRIPTION DRUG
Esmolol hydrochloride is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. Esmolol hydrochloride is also indicated in noncompensatory sinus tachycardia where, in the physician’s judgment, the rapid heart rate requires specific intervention. Esmolol hydrochloride is not intended for use in chronic settings where transfer to another agent is anticipated. Esmolol hydrochloride is indicated for the treatment of tachycardia and hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anesthesia, and in the postoperative period, when in the physician’s judgment such specific intervention is considered indicated. Use of esmolol hydrochloride to prevent such events is not recommended. Esmolol hydrochloride is contraindicated in patients with sinus bradycardia, heart block
Esmolol Hydrochloride Injection NDC 0641-2965-45, 100 mg - 10 mL Ready-to-use Vials, Package of 25 Store at 25˚C (77˚F). Excursions permitted to 15˚-30˚C (59˚-86˚F). [See USP Controlled Room Temperature.] PROTECT FROM FREEZING. Avoid excessive heat. Manufactured for Baxter Healthcare Corporation Deerfield, IL 60015 USA Baxter is a registered trademark of Baxter International Inc. U.S. Patent Nos. 6,310,094 and 6,528,540. For Product Inquiry 1 800 ANA DRUG (1-800-262-3784) MLT-01608/4.0
New Drug Application
ESMOLOL HYDROCHLORIDE- ESMOLOL HYDROCHLORIDE INJECTION WEST WARD PHARMACEUTICAL CORPORATION ---------- ESMOLOL HYDROCHLORIDE INJECTION Ready-to-use Vials 10 mL Vials Iso-Osmotic Solution of Esmolol Hydrochloride in Sodium Chloride FOR INTRAVENOUS USE CAN BE USED FOR DIRECT INTRAVENOUS USE. Esmolol Hydrochloride concentration = 10 milligrams/mL (10,000 micrograms/mL) SINGLE PATIENT USE ONLY NO PRESERVATIVES ADDED RX ONLY DESCRIPTION Esmolol hydrochloride is a beta -selective (cardioselective) adrenergic receptor blocking agent with a very short duration of action (elimination half-life is approximately 9 minutes). Esmolol Hydrochloride is: (±)-Methyl p- [2-hydroxy-3- (isopropylamino) propoxy] hydrocinnamate hydrochloride and has the following structure: Esmolol hydrochloride has the empirical formula C H NO Cl and a molecular weight of 331.8. It has one asymmetric center and exists as an enantiomeric pair. Esmolol hydrochloride is a white to off-white crystalline powder. It is a relatively hydrophilic compound which is very soluble in water and freely soluble in alcohol. Its partition coefficient (octanol/water) at pH 7.0 is 0.42 compared to 17.0 for propranolol. ESMOLOL HYDROCHLORIDE INJECTION Esmolol Hydrochloride Injection is a clear, colorless to light yellow, sterile, nonpyrogenic, iso- osmotic solution of esmolol hydrochloride in sodium chloride. 100 MG, 10 ML SINGLE DOSE VIAL– Each mL contains 10 mg Esmolol Hydrochloride, 5.9 mg Sodium Chloride, USP and Water for Injection, USP; buffered with 2.8 mg Sodium Acetate Trihydrate, USP and 0.546 mg Glacial Acetic Acid, USP. Sodium Hydroxide and/or Hydrochloric Acid added, as necessary to adjust pH to 5.0 (4.5-5.5). CLINICAL PHARMACOLOGY Esmolol hydrochloride is a beta -selective (cardioselective) adrenergic receptor blocking agent with rapid onset, a very short duration of action, and no significant intrinsic sympathomimetic or membrane 1 16 26 4 1 stabilizing activity at therapeutic dosages. Its elimination half-life after intravenous infusion is approximatel Read the complete document